as on December 3, 2025 at 2:29 am IST
Day's Low
Day's High
2.53%
Downside
0.95%
Upside
52 Week's Low
52 Week's High
31.88%
Downside
14.74%
Upside
Check Pacira Pharmaceuticals, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.1B
EPS (TTM)
2.9592
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.48%
PE Ratio (TTM)
50.15
Industry PE ratio
-0.36547231270358305
PEG Ratio
-3.83
EBITDA
150.6M
Revenue (TTM)
716.8M
Profit Margin
2.99%
Return On Equity TTM
2.90%
Track how Pacira Pharmaceuticals, Inc. P/E has moved over time to understand its valuation trends.
Pacira Pharmaceuticals, Inc. in the last 5 years
Lowest (5.36x)
September 30, 2024
Industry (-0.37x)
December 2, 2025
Today (50.15x)
December 2, 2025
Highest (32.47x)
March 31, 2021
Today’s Price to Earnings Ratio: 50.15x
Compare market cap, revenue, PE, and other key metrics of Pacira Pharmaceuticals, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $1.1B | -61.31% | 50.15 | 2.99% | |
| BUY | $21.7B | NA | 18.19 | 40.65% | |
| BUY | $43.8B | NA | 22.23 | 13.81% | |
| BUY | $15.2B | 55.27% | 36.4 | 15.95% | |
| BUY | $56.8B | -19.94% | 21.62 | 28.21% |
The Pacira Pharmaceuticals, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Pacira Pharmaceuticals, Inc. investment value today
Current value as on today
₹1,41,379
Returns
₹41,379
(+41.38%)
Returns from Pacira Pharmaceuticals, Inc. Stock
₹35,261 (+35.26%)
Dollar Returns*
₹6,118 (+6.12%)
Based on 16 analysts
93.75%
Buy
6.25%
Hold
0.00%
Sell
Based on 16 analysts, 93.75% of analysts recommend a 'BUY' rating for Pacira Pharmaceuticals, Inc.. Average target price of $30.17
Get share price movements and forecasts by analysts on Pacira Pharmaceuticals, Inc..
What analysts predicted
20.15%UPSIDE
Target Price
$30.17
Current Price
$24.09
Analyzed by
16 Analysts
Target
$30.17
Pacira Pharmaceuticals, Inc. target price $30.17, a slight upside of 20.15% compared to current price of $24.09. According to 16 analysts rating.
Search interest for Pacira Pharmaceuticals, Inc. Stock has increased by 114% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:114% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 21 October
Tue, 06:05 PM
-Pacira Biosciences received a PIV Notice from WhiteOak regarding a generic version of EXPAREL, asserting patent invalidity.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 1 Year
![]()
In the last 1 year, PCRX has outperformed top 5 stocks with highest market-cap in its industry
Price Rise
![]()
In the last 1 year, PCRX stock has moved up by 42.1%
Profit Spike
![]()
Netprofit is up for the last 2 quarters, -4.84M → 5.43M (in $), with an average increase of 189.2% per quarter
Against Peers
![]()
In the last 3 years, United Therapeutics Corporation has given 72.3% return, outperforming this stock by 122.1%
Revenue Fall
![]()
Revenue is down for the last 2 quarters, 181.09M → 179.51M (in $), with an average decrease of 0.9% per quarter
| Organisation | Pacira Pharmaceuticals, Inc. |
| Headquarters | 5401 West Kennedy Boulevard, Tampa, FL, United States, 33609 |
| Industry | Health Technology |
| CEO | Mr. Frank D. Lee |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Shawn M. Cross | Chief Financial Officer |
Ms. Lauren Bullaro Riker | Principal Accounting Officer & Senior VP of Finance |
Mr. Christopher C. Young | Chief Manufacturing Officer |
Ms. Krys Corbett Esq. | Chief Business Officer |
Mr. Frank D. Lee | CEO & Director |
Ms. Kristen Williams Esq., J.D. | Chief Administrative Officer & Secretary |
Dr. Jonathan Slonin M.D. | Chief Medical Officer |
Ms. Susan Mesco | Head of Investor Relations |
Mr. Anthony Molloy III, Esq. | Chief Legal & Compliance Officer |
Mr. Brendan P. Teehan | Chief Commercial Officer |
Pacira Pharmaceuticals, Inc. share price today is $24.09 as on at the close of the market. Pacira Pharmaceuticals, Inc. share today touched a day high of $24.32 and a low of $23.48.
Pacira Pharmaceuticals, Inc. share touched a 52 week high of $27.64 on and a 52 week low of $16.41 on . Pacira Pharmaceuticals, Inc. stock price today i.e. is closed at $24.09,which is 12.84% down from its 52 week high and 46.80% up from its 52 week low.
Pacira Pharmaceuticals, Inc. market capitalisation is $0.00T as on .
Indian investors can start investing in Pacira Pharmaceuticals, Inc. (PCRX) shares with as little as ₹89.935 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹899.35 in Pacira Pharmaceuticals, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Pacira Pharmaceuticals, Inc. share’s latest price of $24.09 as on December 3, 2025 at 2:29 am IST, you will get 0.4151 shares of Pacira Pharmaceuticals, Inc.. Learn more about
fractional shares .
Pacira Pharmaceuticals, Inc. stock has given -61.31% share price returns and 21.48% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?